Unique ID issued by UMIN | UMIN000026509 |
---|---|
Receipt number | R000030407 |
Scientific Title | Efficacy of Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers |
Date of disclosure of the study information | 2017/03/13 |
Last modified on | 2017/03/11 14:20:43 |
Efficacy of Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers
Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers
Efficacy of Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers
Breast Cancer Surveillance in Japanese BRCA1/2 Mutation Carriers
Japan |
BRCA1/2 Mutation Carriers
Breast surgery | Laboratory medicine |
Malignancy
YES
To determine the clinical benefits of surveillance with half-yearly ultrasonography, clinical breast examination (CBE), annual mammography, and magnetic resonance imaging (MRI) in the early detection of breast cancer in Japanese BRCA1/2 Mutation Carriers
Efficacy
We investigated the distinct roles of mammography, ultrasonography, MRI, and CBE for the detection of breast cancer in women with BRCA1/2 mutations. The medical records of participants who were confirmed to have BRCA1/2 mutations during genetic counseling between January 1, 2000 and October 31, 2016 were reviewed.
Observational
Not applicable |
Not applicable |
Female
BRCA1/2 mutation carriers
The individuals who do not wish to participate to this study.
100
1st name | |
Middle name | |
Last name | Masami Arai, Satoko Shimada |
Cancer Institute Hospital
clinical genetic oncology
3-8-31, Ariake, koto-ku, Tokyo
03-3520-0111
marai@jfcr.or.jp
1st name | |
Middle name | |
Last name | Masami Arai, Satoko Shimada |
Cancer Institute Hospital
clinical genetic oncology
3-8-31, Ariake, koto-ku, Tokyo
03-3520-0111
marai@jfcr.or.jp
Cancer Institute Hospital
department of clinical genetic oncology, breast center
None
Other
NO
2017 | Year | 03 | Month | 13 | Day |
Unpublished
Completed
2016 | Year | 11 | Month | 30 | Day |
2016 | Year | 12 | Month | 05 | Day |
The aim of this study was to determine the clinical benefits of surveillance in BRCA1/2 mutation carriers with half-yearly ultrasonography, CBE, annual mammography, and MRI in the early detection of breast cancer.
2017 | Year | 03 | Month | 11 | Day |
2017 | Year | 03 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030407
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |